These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23356529)

  • 1. A comparison of the Niagara and Medcomp catheters for continuous renal replacement therapy.
    Fealy N; Kim I; Baldwin I; Schneider A; Bellomo R
    Ren Fail; 2013; 35(3):308-13. PubMed ID: 23356529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the Niagara™ and Dolphin® catheters for continuous renal replacement therapy.
    Kim I; Fealy N; Baldwin I; Bellomo R
    Int J Artif Organs; 2011 Nov; 34(11):1061-6. PubMed ID: 22183519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional coagulation and thromboelastograph parameters and longevity of continuous renal replacement circuits.
    Holt AW; Bierer P; Glover P; Plummer JL; Bersten AD
    Intensive Care Med; 2002 Nov; 28(11):1649-55. PubMed ID: 12415456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of catheters of different lengths to achieve right atrium versus superior vena cava placement for continuous renal replacement therapy.
    Morgan D; Ho K; Murray C; Davies H; Louw J
    Am J Kidney Dis; 2012 Aug; 60(2):272-9. PubMed ID: 22497790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filter lifespan in critically ill adults receiving continuous renal replacement therapy: the effect of patient and treatment-related variables.
    Dunn WJ; Sriram S
    Crit Care Resusc; 2014 Sep; 16(3):225-31. PubMed ID: 25161027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial and extended use of femoral versus nonfemoral double-lumen vascular catheters and catheter-related infection during continuous renal replacement therapy.
    Chua HR; Schneider AG; Sherry NL; Lotfy N; Chan MJ; Galtieri J; Wong GR; Lipcsey M; Matte Cde A; Collins A; Garcia-Alvarez M; Bellomo R
    Am J Kidney Dis; 2014 Dec; 64(6):909-17. PubMed ID: 24882583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variables associated with circuit life span in critically ill patients undergoing continuous renal replacement therapy: a prospective observational study.
    Zhang Z; Ni H; Lu B
    ASAIO J; 2012; 58(1):46-50. PubMed ID: 22210650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertion side, body position and circuit life during continuous renal replacement therapy with femoral vein access.
    Kim IB; Fealy N; Baldwin I; Bellomo R
    Blood Purif; 2011; 31(1-3):42-6. PubMed ID: 21160179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular access site influences circuit life in continuous renal replacement therapy.
    Crosswell A; Brain MJ; Roodenburg O
    Crit Care Resusc; 2014 Jun; 16(2):127-30. PubMed ID: 24888283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure.
    Chua HR; Baldwin I; Bailey M; Subramaniam A; Bellomo R
    J Crit Care; 2012 Dec; 27(6):744.e7-15. PubMed ID: 23102533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature circuit clotting due to likely mechanical failure during continuous renal replacement therapy.
    Kim IB; Fealy N; Baldwin I; Bellomo R
    Blood Purif; 2010; 30(2):79-83. PubMed ID: 20664199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT).
    Brophy PD; Somers MJ; Baum MA; Symons JM; McAfee N; Fortenberry JD; Rogers K; Barnett J; Blowey D; Baker C; Bunchman TE; Goldstein SL
    Nephrol Dial Transplant; 2005 Jul; 20(7):1416-21. PubMed ID: 15855212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of saline flush to prevent filter clotting in continuous renal replacement therapy without anticoagulant.
    Panphanpho S; Naowapanich S; Ratanarat R
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S105-10. PubMed ID: 21721435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faster Blood Flow Rate Does Not Improve Circuit Life in Continuous Renal Replacement Therapy: A Randomized Controlled Trial.
    Fealy N; Aitken L; du Toit E; Lo S; Baldwin I
    Crit Care Med; 2017 Oct; 45(10):e1018-e1025. PubMed ID: 28658026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of AN69 ST membrane on filter lifetime in continuous renal replacement therapy without anticoagulation in patients with high risk of bleeding].
    Yin Y; Zhao C; Hu Z; Wei S; Huo Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):343-8. PubMed ID: 26003637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of software algorithm driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: the Filter Life in Renal Replacement Therapy pilot trial.
    Brain MJ; Roodenburg OS; Adams N; McCracken P; Hockings L; Musgrave S; Butt W; Scheinkestel C
    Crit Care Resusc; 2014 Jun; 16(2):131-7. PubMed ID: 24888284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine output is associated with prognosis in patients with acute kidney injury requiring continuous renal replacement therapy.
    Oh HJ; Shin DH; Lee MJ; Ko KI; Kim CH; Koo HM; Doh FM; Kwon YE; Kim YL; Nam KH; Park KS; An SY; Park JT; Han SH; Yoo TH; Kang SW
    J Crit Care; 2013 Aug; 28(4):379-88. PubMed ID: 23582311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study.
    Parienti JJ; Mégarbane B; Fischer MO; Lautrette A; Gazui N; Marin N; Hanouz JL; Ramakers M; Daubin C; Mira JP; Charbonneau P; du Cheyron D;
    Crit Care Med; 2010 Apr; 38(4):1118-25. PubMed ID: 20154599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.